Ginsenoside Rh4 Improves Hepatic Lipid Metabolism and Inflammation in a Model of NAFLD by Targeting the Gut Liver Axis and Modulating the FXR Signaling Pathway

Ginsenoside Rh4 Improves Hepatic Lipid Metabolism and Inflammation in a Model of NAFLD by Targeting the Gut Liver Axis and Modulating the FXR Signaling Pathway

Non-alcoholic fatty liver disease (NAFLD) is a series of disorders of liver metabolism caused by the accumulation of lipids in the liver, which is considered the main cause of hepatocellular carcinoma. Our previous study demonstrated the promising efficacy of ginsenoside Rh4 in improving the intesti...

Full description

Bibliographic Details
Main Authors: Siming Yang, Zhiguang Duan, Sen Zhang, Cuiying Fan, Chenhui Zhu, Rongzhan Fu, Xiaoxuan Ma, Daidi Fan
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Foods
Subjects:
ginsenoside Rh4
NAFLD
gut–liver axis
FXR
bile acids
SCFAs
Online Access:https://www.mdpi.com/2304-8158/12/13/2492

Internet

https://www.mdpi.com/2304-8158/12/13/2492

Similar Items